UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007710
Receipt number R000009090
Scientific Title Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants
Date of disclosure of the study information 2012/04/13
Last modified on 2018/04/15 10:07:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants

Acronym

Study about live vaccines in children receiving immunosuppressants

Scientific Title

Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants

Scientific Title:Acronym

Study about live vaccines in children receiving immunosuppressants

Region

Japan


Condition

Condition

Patients under treatment of immunosuppressants (CsA, FK, MZR, NNF, AZP)

Classification by specialty

Gastroenterology Nephrology Infectious disease
Pediatrics Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examination of the efficacy and safety of immunization with attenuated live vaccines in patients receiving immunosuppressants.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) Analysis of antibody acquisition after vaccination classified by each virus.
2) Analysis of maintenance of acquired immunity classified by each virus especially after 1 year.
3) Analysis of incididence of adverse events classified by each virus.

Key secondary outcomes

1) Analysis of causes of vaccine failure.
2) Analysis of causes of adverse events.
3) Analysis of effect for prevention of virus infection.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Live attenuated vaccine

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Equal or more than one years old.
2. Patients under treatment of immunosuppressants (CsA, FK, MZR, MMF, AZP, MTX)
3. Negative or borderline antibody titer of one or more of the following viruses: measles, rubella, varicella, or mumps.
4. Patients who cannot discontinue immunosuppressants because of primary disease.
5. Inactive primary disease.
6. Normal cellular immunity (CD4 counts>500/mm3, PHA lymphocyte stimulatory test-stimulation index>101.6).
7. Serum IgG level>300mg/dl
8. FK trough level<10ng/ml or CsA trough level<100ng/ml.
9. Approved by the committee for attenuated live vaccination in children receiving immunosuppressants.

Key exclusion criteria

1. Steroid use of more than 1mg/kg/d.
2. For renal transplant recipients, <1 year since transplantation or acute rejection within the previous 6 months.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichi Kamei

Organization

National Center for Child Health and Development

Division name

Nephrology and Rheumatology

Zip code


Address

2-10-1, Okura, Setagaya-ku, Tokyo

TEL

+81-3-5494-7128

Email

kamei-k@ncchd.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koichi Kamei

Organization

National Center for Child Health and Development

Division name

Nephrology and Rheumatology

Zip code


Address

2-10-1, Okura, Setagaya-ku, Tokyo

TEL

+81-3-5494-7128

Homepage URL


Email

kamei-k@ncchd.go.jp


Sponsor or person

Institute

Department of Nephrology and Rheumatology
National Center for Child Health and Development

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 13 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 04 Month 09 Day

Date of IRB


Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry

2018 Year 03 Month 31 Day

Date trial data considered complete

2018 Year 03 Month 31 Day

Date analysis concluded

2018 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2012 Year 04 Month 10 Day

Last modified on

2018 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009090


Research Plan
Registered date File name
2017/10/14 研究計画書20161122.doc

Research case data specifications
Registered date File name
2017/10/14 接種回数 n=169 201105-201701.xlsx

Research case data
Registered date File name
2017/10/14 接種回数 n=169 201105-201701.xlsx